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Abstract 
Purpose: Hypertension is a growing public health problem in China; however, little is known about health-related 
quality of life (HRQoL) especially health state utility (HSU) of patients with hypertension in rural China. This study 
aimed to examine the HSU as measured by SF-6D and to investigate its associated factors among middle and old 
aged patients with hypertension in rural China.
Methods: Data were collected from twelve villages in Shandong Province in 2016. SF-36 was administrated to meas-
ure HRQoL of middle and old aged patients with hypertension and was got to the SF-6D values using Hong Kong’s 
tariff. Descriptive analyses, such as demographic characteristics, socio-economic status, and utility, were stratified by 
hypertension classification. Multiple linear regression models were applied to assess the associated factors of HSU.
Results: A total of 933 (response rate:86.4%) middle and old aged patients (69.1 ± 8.2 years) with hypertension par-
ticipated in the study. 39.4% of participants were male; 44.2% had stage I hypertension; 26.4% had stage II and above. 
The mean score of SF-6D utility score was 0.743 (SD: 0.14, range: 0.32–1.00, median: 0.756, Interquartile range:0.634–
0.859). Being female (β = −0.046), having two or more comorbidities (2 vs. 1 β = −0.066; > 3 vs. 1 β = −0.098) and the 
health expenditure higher than 2000 RMB (2000–3999 vs.< 2000 β = −0.042; 4000–5999 vs. < 2000 β = −0.046; > 6000 
vs. < 2000 β = −0.071) were significantly associated with lower SF-6D overall score; while being farmer (β = 0.032), 
having high household income (10,000–14,999 vs. < 5000 β = 0.045; > 15,000 vs. < 5000 β = 0.064) and having stage 
I and above hypertension (stage I vs. Normotensive β = 0.047; stage II vs. Normotensive β = 0.079; stage III vs. Normo-
tensive β = 0.095) were significantly associated with higher SF-6D overall score.
Conclusion: SF-6D was capable to measure quality of life middle and old aged patients with hypertension in China. 
And multiple factors were demonstrated to be significantly associated with quality of life.
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Introduction
Hypertension is the strongest risk factor of cardiovascu-
lar and cerebrovascular diseases as well as the related dis-
abilities and mortality in worldwide [1]. About 80% of all 
cardiovascular mortality occurs in low-income and mid-
dle-income countries including China, where the greatest 
burden of hypertension has been observed [2]. A recent 
nation-wide survey in China showed that nearly half of 
Chinese adults aged 35–75 years had hypertension, and 
among them, a third had stage II and above hypertension 
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[3]; more than two-thirds of the survey population were 
not treated, and fewer than one in twelve were in con-
trol of their blood pressure. Health-related quality of life 
(HRQOL) of individuals with hypertension was lower 
than normotensive individuals [4–7]. In China, rural 
population account for over 40% of the whole popula-
tion, while in Shandong province, 60% of the population 
are in the rural areas [8]. The prevalence of hypertension 
continues to rise in rural areas and has surpassed that in 
urban area [3]. However, rural people were less likely to 
be aware of, treated for, and controlled for hypertension 
[3, 9]. Therefore, as a chronic non-communicable disease, 
hypertension has unsatisfactory morbidity and control in 
China rural, influencing seriously hypertension patients’ 
quality of life, which warranted further research.
HRQoL is a multidimensional concept encompassing a 
patient’s emotional, physical, and social functioning [10]. 
Various instruments of HRQOL have been developed 
for the general population and populations with health 
conditions including hypertension [11, 12]. Based on the 
literature review, most of the previous studies measured 
HRQoL of hypertension using the generic instruments, 
such as MOS (Medical Outcome Study) and 36-Item 
Short-Form Health Survey (SF-36), while few studies 
used the preference-based measurements among patients 
with hypertension [13–15].
Health state utility (HSU) is essential to cost-utility 
analysis (CUA) in health administration and health 
economics [16]. The HSU scores can be elicited using 
multi-attributes utility (MAU) instruments, such as the 
EuroQol-5 Dimensions (EQ-5D) instrument, the Short-
Form Six Dimensions (SF-6D) derived from the SF-36, 
and the Health Utilities Index (HUI). With regard to the 
preference-based instruments of HRQOL in patients 
with hypertension, there have been some studies apply-
ing EQ-5D [5, 7, 17–20] and HUI [21, 22]. To our best 
knowledge, only one study conducted in Vietnam used 
SF-6D to evaluate the utility value of patients with hyper-
tension [23]. There has been no similar data in China.
In addition, identifying the associated factors espe-
cially the modifiable factors are important for further 
development of evidence-based health promotion and 
intervention programs among rural population in China. 
Evidence on this issue was scarce. Based on the existing 
literature, age, gender, marital status, income, education 
level, awareness of hypertension, and comorbidities were 
associated with quality of life of patients with hyperten-
sion [5]. However, little is known about the associated 
factors of quality of life among patients in rural areas in 
China.
Therefore, this study aimed to evaluate the perfor-
mance of SF-6D as a measurement of health status util-
ity and to assess the associated factors of quality of life 
among middle and old aged patients with hypertension 
in rural areas, China. This study would benefit the future 
studies in China or in other countries by providing the 
reference data of SF-6D of patients with hypertension for 
comparison with other populations.
Methods
Setting and sample
This study was conducted in Shandong Province, which 
is located in middle east of China, with a population of 
about 100 million [24]. In 2016, the gross regional prod-
uct of Shandong Province amounted to RMB 6802 billion 
(US$1024 billion), ranking as the third-largest economy 
in China [24]. It illustrates the Chinese economy and 
society in miniature to some extent. Like China, Shan-
dong also presents a gradient regarding the level of eco-
nomic development across the east, middle and west 
areas, that is, the economy in the east is better than the 
other two areas. We followed the randomized sampling 
principles to optimize the representativeness of the study 
population by selecting villages from different geographic 
areas. In addition, the economy, society and culture do 
not diverse much in rural areas in Shandong Province. 
Hence, the study population in our study has a relatively 
good representativeness.
A community-based survey was conducted in July, 
2016. We applied the method of stratified random sam-
pling to select the study population. Three tiers were 
used. To ensure the representation of our sample, firstly, 
we selected three cities in the east, middle and west of 
Shandong Province. Secondly, from these three cities, we 
selected three counties based on their economic level, i.e. 
high, middle and low development of economy. Thirdly, 
two villages were selected randomly from each county. 
Two townships were then selected randomly from each 
county, and two villages were further randomly selected 
from each township. Finally, twelve villages were enrolled.
In 2009, the New Health System Reform was launched 
in China, and all diagnosed patients with hypertension 
should be registered and managed by village doctors 
according to the Basic Public Health Services Regula-
tion 2009 [25]. In this study, we recruited all patients with 
hypertension aged 50  years and above in these twelve 
villages based on the registration at the village doctors. 
Patients were excluded if (1) they were unwilling to give 
informed consent; (2) they had the disease that severely 
influenced the cognitive function to comprehend the 
questionnaire; or (3) they did not register at the vil-
lage doctors. In total, one thousand and eighty patients 
were eligible for the survey. One hundred and twenty-
six patients were excluded because they were unavail-
able for the interview. Further, twenty-one patients were 
excluded due to incomplete answers to SF-36. The final 
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study sample consists of 933 participants (response rate: 
86.4%).
Instruments
Twenty-two interviewers were recruited among the 
medical ungraduated and graduate students at Shan-
dong University. The interviewers were trained several 
times by the project management team members with 
regard to the study protocol, targeted population, ques-
tionnaire, interview skills, recording data, and the proper 
method to measure hypertension. They interviewed the 
participants in a face-to-face way. To control the quality 
of the questionnaire, interviewers carefully checked the 
questionnaires at the end of the day, and if there were any 
questions, they asked investigators to clarify.
HRQOL measurement
HRQOL was measured by the Chinese version of SF-36 
[28], from which the SF-6D was derived [29]. For more 
information about SF-36, see the links: https ://www.quali 
tymet ric.com/produ cts/licen se/; and https ://www.rand.
org/healt h/surve ys_tools /mos/36-item-short form.html. 
SF-6D includes six dimensions, i.e., physical functioning, 
role limitations, social functioning, pain, mental health, 
and vitality. There are four to six answer options of each 
dimension, resulting in 18,000 possible health states [29]. 
The SF-6D has been used to calculate health utility scores 
in terms of non-communicable diseases [30, 31]. In the 
present study, we used the Chinese-specific tariff devel-
oped among Chinese adults in Hong Kong to get SF-6D 
values from SF-36 [32]. The range of the overall score is 
0.32–1.00 [29]. The higher score indicates better health 
status.
Hypertension measurement
 Blood Pressure (BP) was measured using an electronic 
sphygmomanometer (OMRON, HEM-7211). Accord-
ing to the Chinese guideline of the management of 
hypertension [27], the blood pressure was divided into 
four categories: normotensive hypertension, hyperten-
sion stage I, II, and III. Normative hypertension was 
defined as systolic blood pressure < 140  mmHg or dias-
tolic blood pressure < 90  mmHg; Hypertension stage 
I: 140  mmHg ≤ systolic blood pressure < 160  mmHg 
or 90  mmHg ≤ diastolic blood pressure < 100  mmHg; 
Hypertension stage II: 160  mmHg ≤ Systolic blood 
pressure < 180  mmHg or 100  mmHg ≤ diastolic blood 
pressure < 110  mmHg; Hypertension stage III: Systolic 
blood pressure ≥ 180  mmHg or diastolic blood pres-
sure ≥ 110 mmHg [27].
Associated factors
A standardized questionnaire was designed to collect 
data, including socio-demographic information on the 
individuals and households, health-related behaviors, 
health conditions (hypertension and its complications, 
family history, and the economic burden of hyperten-
sion), quality of life, and utilization of health services. 
Based on the previous studies [19, 20, 33], we measured 
the potential associated factors of quality of life of hyper-
tension patients, including socio-demographic factors, 
lifestyle-related factors, and the medical treatments of 
hypertension These factors were demonstrated to be sig-
nificantly associated with the good/poor quality of life of 
hypertension patients in the previous studies.
Data collection
Questionnaire survey
During the questionnaire survey, the trained-interview-
ers informed the participants about the basic principles 
of the survey and gave some instruction about how to fill 
in the questionnaire. They provided help when the par-
ticipants had any questions. When the questionnaire was 
finished, the interviewer immediately checked the miss-
ing answers, and asked the participate to fill in again.
Hypertension measurement
Two blood pressure (BP) measurements were obtained 
from each participant by trained and certified observ-
ers according to a common protocol. Participants in the 
sitting position after 5  min of rest. Participants were 
instructed to refrain from alcohol, cigarette smoking, cof-
fee/tea, and exercise for at least 30  min before their BP 
measurement. The average of two or three readings of 
systolic BP and Diastolic BP was used to describe each 
participant’s BP. It’s worth noting that some participants 
showed normal blood pressure when they participate in 
the survey because they had taken measures to control 
their hypertension, such as taking regular medication.
Statistical analysis
We described the frequencies of options of each item of 
SF-6D answered by participants. Kolmogorov–Smirnov 
test (K–S test) was applied to evaluate the distribution of 
SF-6D scores.
Differences in the overall score of SF-6D across the 
subgroups regarding the variables of attributes of the 
study population were assessed by one-way analysis 
of variance (ANOVA) when the variables were nor-
mally distributed, otherwise the Mann–Whitney U 
rank-sum test was used. Multivariate linear regression 
was applied to assess the associated factors of SF-6D 
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overall score. The statistical significance level was 
indicated as p < 0.01. All statistical analyses were per-
formed using SPSS statistics (SPSS version 22.0 Inc., 
Chicago, IL, USA).
Ethics approval
This study was conducted according to the guideline pro-
posed in the World Medical Association of Helsinki [26], 
and the ethical approval was obtained from the Ethics 
Review Board of the School of Public Health, Shandong 
University (Reference No. 20140301). Informed consent 
was obtained from all participants after a detailed expla-
nation of the study by the interviewers.
Results
Participants’ characteristics
Table 1 presented the characteristics of the participants. 
The mean age of the study population was 69.1 (SD = 8.2) 
years old. About 40% of the participants were male and 
about half of the population were illiterate (48.3%). More 
than 80% participants were farmers and more than half 
had household income of less than 10,000 RMB a year. 
Nearly 70% of the participants had hypertension for more 
than 5 years. The majority (more than 80%) of non-drug 
therapy patients followed alimentary control, work-rest 
schedule and rest, and emotion control. In terms of drug 
compliance, the condition that patients’ discontinuation 
medication by themselves was more serious. Almost one-
third of participants were classified as normotensive and 
around 45% were in stage I, 26.4% were above the stage II.
Table  2 showed the frequencies of each level of six 
dimensions of SF-6D: 47.3%, 44.7%, 41.4%, 39.9%, 32.5%, 
and 37.6% of participants chose the highest level of health 
regarding each dimension, i.e. Physical functioning, Role 
limitations, Social functioning, Pain, Mental health and 
Vitality. Meanwhile, 24% of participants chose the worst 
level of health in the Role limiting dimension. Overall, 
2.5% participants scored the full health (‘111,111’) and 
0.1% scored the worst health (‘645,655’) based on the 
SF-6D health state classification system. Figure  1 pre-
sented the distribution of SF-6D overall score or the so-
called utility value of the study population. The skewness 
coefficient and kurtosis coefficient of the utility were 
-0.255 and 0.775.
Differences in SF‑6D overall score across subgroups
Table  3 showed the differences in SF-6D overall score 
across subgroups. The mean score of SF-6D utility value 
was 0.743 (SD: 0.141) and the median was 0.756 [Inter-
quartile range 0.632–0.859]. The relatively low scores 
were presented in participants who were female, not 
educated, not married, living alone, and who had low 
Table 1 Participants’ characteristics (n = 933)
 Variables N (%) 
Gender 
Male 368 (39.4) 
Female 565 (60.6) 
Age* 
50–59 86 (9.2) 
60–69 398 (42.7) 
70–79 349 (37.4) 
> 80 76 (8.1) 
Education 
Illiteracy 451 (48.3) 
Primary 278 (29.8) 
Junior 160 (17.1) 
Senior or above 44 (4.7) 
Marital status 
Married 781 (83.7) 
Others 152 (16.3) 
Way of residence 
Living alone 115 (12.3) 
Living with a spouse 587 (62.9) 
Others 231 (24.8) 
Occupation 
Farmers 763 (81.8) 
Others 170 (18.2) 
Household income (RMB)* 
< 5000 342 (36.7) 
5000–9999 176 (18.9) 
10,000–14,999 135 (14.5) 
> 15000 280 (30.0) 
Health expenditure (RMB)* 
< 2000 390 (41.8) 
2000–3999 95 (10.2) 
4000–5999 117 (12.5) 
> 6000 250 (26.8) 
Comorbid diseases 
1 552 (59.2) 
2 301 (32.3) 
> 3 80 (8.6) 
Health insurance 
No 26 (2.8) 
Yes 907 (97.2) 
Hypertension stages 
normotensive 274 (29.4) 
I 412 (44.2) 
II 172 (18.4) 
III 75 (8.0) 
Duration of hypertension (Years) 
< 5 318 (34.1) 
5–9 271 (29.0) 
10–14 153 (16.4) 
> 15 191 (20.5) 
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household income, having high health expenditure, 
with more comorbidities and having no hypertension 
(p < 0.01).
Associated factors of SF‑6D utility score
Table  4 presented the results of multivariate linear 
regression analyses. Being female, having two or more 
comorbidities, and having higher than 2000 RMB health 
expenditure were associated with lower SF-6D overall 
score compared with their peer in the reference groups. 
Being a farmer, having stage I and above hypertension, 
having higher household income were associated with 
higher SF-6D overall score compared with the reference 
groups.
Discussion
Rural population in China generally have relatively poor 
material condition and relatively low educational level 
and health literacy [37, 38]. Chronic conditions and chal-
lenges due to aging are common among this population 
[34, 34]. However, the access to and the use of health care 
services and health insurance are limited [36]. In terms 
of hypertension management, rural population are less 
likely aware of hypertension early signs and less likely 
seek for medical help and adhere to medical treatment 
plan [37, 38]. Taken the above features into account, 
rural population may be at risk of suboptimal health-
related quality of life. Therefore, it is crucial to extend the 
understand of associated factors of quality of life among 
patients with hypertension in rural area in China.
We have examined the utility of SF-6D among a com-
munity-dwelled participant in rural China. SF-6D overall 
score was significantly different across subgroups regard-
ing gender, education, marriage, way of residence, house-
hold income, health expenditure, comorbidities, and 
hypertension stage. Gender, occupation, health expendi-
ture, household income, comorbidities, and hypertension 
stage were associated with higher or lower SF-6D overall 
score.
We found that the utility value of SF-6D in the pre-
sent study was lower than that of EQ-5D when these two 
instruments were used to measure HRQOL of patients 
with hypertension[20, 33]. The mean utility value of 
SF-6D in our study (i.e. 0.743) was lower than the mean 
utility value of EQ-5D among participants with hyper-
tension reported by two previous studies (i.e. 0.921 and 
0.850). It was also lower than the normative value of 
SF-6D measured in Hongkong population with hyper-
tension (i.e. 0.746) [39]. Our study did not suggest the 
floor effect of SF-6D, which was not consistent with the 
study by Ferreira et al. [40]. The differences in the utility 
values across subgroups may be due to different instru-
ments to measure quality of life. EQ-5D mainly focuses 
on measuring the physical domain of quality of life. There 
are four dimensions reflecting physical aspects and one 
dimension is about mental health. However, SF-6D is 
Note: OECD Health Statistics 2018: (https ://www.oecd.org/els/healt h-syste ms/
healt h-data.htm)
Monetary conversion rate: US$1 = RMB 6.2(2015) US$1 = RMB 6.6(2016); 
US$1 = RMB 6.8(2017);
Others in Marital status: unmarried, divorced, widowed, etc.
Others in Way of residence: live with friends, other relatives, aunts and uncles, 
children, etc.
Others in Occupation: Work in a public institution such as government, hospital, 
school, etc. work in corporations, work in individual business etc.
* Missing data
Table 1 (continued)
 Variables N (%) 
Non-pharmaceutical therapies 
Exercise 
No 467 (50.5) 
Yes 466 (49.9) 
Alimentary control 
No 154 (16.5) 
Yes 779 (83.5) 
Work-rest schedule 
No 154 (16.5) 
Yes 779 (83.5) 
Emotion control 
No 136 (14.6) 
Yes 797 (85.4) 
Pharmaceutical therapies 
Take medicine in one year 
No 112 (12.0) 
Yes 821 (88.0) 
Take medicine in two weeks 
No 209 (22.4) 
Yes 724 (77.6) 
Pharmaceutical Compliance 
Forget taking medicine * 
No 540 (63.6) 
Yes 309 (36.4) 
Drug discontinuation by patients themselves* 
No 699 (82.3) 
Yes 150 (17.7) 
Drug discontinuation for improvement* 
No 550 (64.8) 
Yes 299 (35.2) 
Drug discontinuation for deterioration* 
No 698 (82.2) 
Yes 151 (17.8) 
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more comprehensive, reflecting the quality of life from 
physical, psychological, social and emotional aspects, 
which was a suitable instrument to measure the impacts 
of hypertension on patient’s health. As a chronic disease, 
hypertension may not have some influences on physical 
health that patients can feel directly, but taking medica-
tion on a daily base and concerns about other complica-
tions due to hypertension may increase the psychological 
burden.
We found that higher educational level was associated 
with higher utility value that can be interpreted as bet-
ter HRQOL, which was consistent with previous studies 
by Zhou et al. [41], and Andrade et al. [42]. The present 
study did not show that older age was associated with 
lower HRQOL score among the hypertensive individuals. 
A previous study indicated that comorbid diseases might 
influence disease severity and body pain/discomfort [43], 
which could result in worse health states. Two study 
results may be related to participants differences.
The present study found that household income was 
associated with poorer HRQoL. Zhang L et  al. suggest 
that people with low household income tended to have 
higher healthcare needs but lacked the financial capac-
ity to pay for health services [20]. High health expendi-
ture is generally considered as an economic burden to the 
household, and it often places households at higher risk 
of catastrophic health expenditure and pushes them into 
poverty, which in turn inevitably has a negative impact 
on people’s HRQoL.
We did not find significant association between marital 
status and HRQOL, which was inconsistent with a pre-
vious study [19]. Zhang et al. showed that marital status 
was one of the factors to impact the HRQoL of patients 
with hypertension and married patients reported higher 
HRQoL than divorced or widowed patients. In our study, 
a large proportion of people were married, it was hard 
to observe the differences in HRQOL across marital 
subgroups.
As reported by previous studies, normally the individual 
with higher stage hypertension had lower HRQOL [44, 
45]. However, the present study found the opposite result 
that the patients with higher stage hypertension reported 
higher HRQOL scores. This may be explained by two rea-
sons. First, hypertension is a chronic disease with a long 
course. It may be asymptomatic or not obvious at the early 
stage, leading to patients’ unawareness [46]. As the disease 
progresses, symptoms begin to appear and begin to affect 
the patient’s feelings and quality of life. In rural China, the 
elderly usually has a low level of education, poor under-
standing of the prognosis of hypertension, and generally 
do not pay attention to the treatment of hypertension 
unless symptoms occur. Only patients with severe symp-
toms of hypertension, which maybe has already affected 
their daily life functioning and quality of life, may seek 
help in terms of hypertension treatment. This may partly 
explain why patients with better blood pressure control in 
this study had a relatively low quality of life. In addition, 
some patients maybe did not perceive hypertension as a 
health condition that can cause severe complications with-
out proper treatment, so they did not adhere to the treat-
ment and maybe rated their quality of life to the normal 
Table 2 Frequencies of each level of six dimensions of SF-6D
PF physical function, RL role limitation, SF social function, BP body pain, MH mental health, VT vitality
Dimension PF RL SF BP MH VT
Level 1 17.6 44.7 41.4 32.5 24.3 16.1
Level 2 47.3 26.8 22.0 4.3 39.9 37.6
Level 3 19.3 4.5 20.4 31.7 21.1 30.4
Level 4 4.6 24.0 10.7 16.7 11.7 12.0
Level 5 8.8 5.6 11.4 3.0 3.9
Level 6 2.5 3.4
Fig. 1 Distribution of SF-6D utilities
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Table 3 Differences in Health State Utility scores across subgroups (n− = 933)
Variables Mean(95%Cl) SD Median IQR 
All
Gender 0.743 (0.734–0.753) 0.141 0.756 0.632–0.859 
Male 0.782 (0.768–0.795) 0.131 0.801 0.700–0.884 
Female 0.718 (0.707–0.730) 0.141 0.725 0.600–0.828 
Age(years)* 
50–59 0.765 (0.736–0.793) 0.133 0.778 0.706–0.863 
60–69 0.757 (0.744–0.771) 0.138 0.769 0.648–0.873 
70–79 0.728 (0.713–0.743) 0.142 0.736 0.611–0.843 
> 80 0.705 (0.670–0.741) 0.156 0.728 0.563–0.834 
Education* 
Illiteracy 0.715 (0.702–0.728) 0.142 0.719 0.596–0.832 
Primary school 0.757 (0.741–0.773) 0.138 0.770 0.654–0.867 
Junior school 0.788 (0.769–0.808) 0.125 0.807 0.716–0.882 
Senior school or above 0.783 (0.739–0.827) 0.144 0.815 0.667–0.886 
Marital status* 
Married 0.747 (0.737–0.757) 0.141 0.762 0.638–0.863 
Others 0.724 (0.701–0.746) 0.138 0.730 0.610–0.838 
Way of residence* 
Living alone 0.711 (0.685–0.736) 0.138 0.714 0.609–0.821 
Living with a spouse 0.738 (0.726–0.750) 0.144 0.757 0.617–0.856 
Others 0.774 (0.757–0.790) 0.129 0.786 0.685–0.874 
Occupation 
Famers 0.734 (0.725–0.744) 0.138 0.745 0.623–0.849 
Others 0.784 (0.761–0.806) 0.148 0.807 0.671–0.911 
Household income (RMB Yuan)* 
< 5000 0.708 (0.693–0.723) 0.142 0.716 0.582–0.819 
5000–9999 0.731 (0.711–0.751) 0.136 0.742 0.607–0.840 
10,000–14,999 0.774 (0.753–0.796) 0.127 0.778 0.704–0.872 
> 15,000 0.779 (0.763–0.796) 0.137 0.799 0.675–0.890 
Health expenditure (RMB Yuan)* 
< 2000 0.776 (0.762–0.790) 0.137 0.801 0.674–0.877 
2000–3999 0.737 (0.717–0.757) 0.139 0.749 0.628–0.854 
4000–5999 0.726 (0.699–0.753) 0.148 0.722 0.604–0.844 
> 6000 0.708 (0.692–0.725) 0.134 0.718 0.600–0.815 
Comorbid diseases* 
1 0.776 (0.765–0.787) 0.131 0.793 0.689–0.874 
2 0.705 (0.689–0.721) 0.141 0.716 0.594–0.813 
> 3 0.664 (0.633–0.694) 0.139 0.649 0.553–0.791 
Health insurance 
No 0.708 (0.646–0.771) 0.155 0.676 0.570–0.858 
Yes 0.744 (0.735–0.754) 0.140 0.758 0.633–0.859 
Hypertension stages* 
Normotensive 0.695 (0.678–0.712) 0.142 0.705 0.625–0.858 
I 0.749 (0.736–0.763) 0.138 0.758 0.638–0.867 
II 0.774 (0.755–0.794) 0.130 0.784 0.633–0.839 
III 0.818 (0.790–0.846) 0.120 0.835 0.631–0.857 
Duration of hypertension 
< 5 0.752 (0.736–0.768) 0.144 0.763 0.650–0.870 
5–9 0.751 (0.735–0.768) 0.140 0.766 0.638–0.868 
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level or better, which may explain the association between 
high blood pressure with better quality of life. This find-
ing indicated that it was necessary to educate the patients 
regarding the knowledge of prognosis of hypertension 
and arouse the attention of patients to importance of early 
control of blood pressure, in order to achieve the effective 
control of BP. Second, the severity of hypertension might 
affect people’s perception of their general health, which 
might influence how they rated their HRQoL. They may 
rate their HRQOL better than normotensive individu-
als after successfully controlling the blood pressure or by 
developing good coping skills. We recommended studies 
in the future to confirm or deny this finding in our study.
Strengths and limitations
The present study has randomly selected a large commu-
nity-based sample of middle and old aged patients with 
hypertension from the community population in rural 
areas in Shandong province, China. Additionally, we have 
measured a comprehensive set of potential associated 
factors of HRQOL.
Our study has some limitations that deserved to men-
tion. First, as a cross-sectional design, the association 
between HRQoL and factors cannot be interpreted 
as causal. Second, there might be other potential fac-
tors that affect HRQoL, such as medication adherence, 
hospital admission, which might cause a deviation of 
Table 3 (continued)
Variables Mean(95%Cl) SD Median IQR 
10–14 0.730 (0.708–0.752) 0.138 0.745 0.603–0.837 
> 15 0.729 (0.709–0.748) 0.138 0.738 0.611–0.838 
Non-pharmaceutical therapies 
Exercise 
No 0.742 (0.729–0.755) 0.143 0.758 0.648–0.859 
Yes 0.745 (0.733–0.758) 0.139 0.753 0.642–0.856 
Alimentary control 
No 0.746 (0.723–0.770) 0.147 0.767 0.641–0.867 
Yes 0.743 (0.733–0.752) 0.140 0.755 0.630–0.857 
Work-rest schedule 
No 0.731 (0.709–0.754) 0.142 0.749 0.606–0.839 
Yes 0.746 (0.736–0.756) 0.141 0.757 0.638–0.863 
Emotion control 
No 0.744 (0.720–0.768) 0.143 0.761 0.639–0.856 
Yes 0.743 (0.734–0.753) 0.141 0.755 0.631–0.860 
Pharmaceutical therapies 
Take medicine in one year 
No 0.747 (0.720–0.774) 0.147 0.745 0.648–0.867 
Yes 0.743 (0.733–0.753) 0.140 0.757 0.630–0.857 
Take medicine in two weeks 
No 0.747 (0.727–0.766) 0.144 0.754 0.646–0.858 
Yes 0.743 (0.732–0.752) 0.140 0.757 0.630–0.859 
Pharmaceutical Compliance 
Forget taking medicine 
No 0.741 (0.729–0.753) 0.141 0.749 0.627–0.856
Yes 0.748 (0.732–0.764) 0.142 0.764 0.648–0.862
Drug discontinuation by patients themselves 
No 0.744 (0.734–0.755) 0.140 0.757 0.637–0.857
Yes 0.739 (0.715–0.762) 0.147 0.758 0.598–0.860
Drug discontinuation for improvement 
No 0.740 (0.728–0.752) 0.141 0.747 0.617–0.857
Yes 0.750 (0.734–0.766) 0.142 0.767 0.650–0.859
Drug discontinuation for deterioration 
No 0.742 (0.731–0.752) 0.141 0.756 0.628–0.857
Yes 0.750 (0.727–0.773) 0.143 0.762 0.650–0.864
ANOVA* p < 0.01
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the results. However, we did not measure in our study. 
Third, EQ-5D has not been investigated in this paper, so 
we were not able to compare the utility value measured 
by SF-6D with the widely-used EQ-5D. Fourth, the age 
groups in this study were middle and old age in a rural 
area. This may influence the generalization of our results 
to the general population. In the selected counties in our 
study, residents who were under 50 years normally were 
not available for the survey because they mostly immi-
grated to the cities and worked there. Fifth, given the 
social, cultural, geographic and economic characteristics 
of Shandong Province, the selected sample in our study 
could not fully represent the rural population in China, 
which may limit the generalization of the findings from 
the present study. We recommended further similar 
studies to be conducted among larger and more repre-
sentative samples in China by selecting random samples 
from North, South, East and West China.
In conclusion, the present study was the first to apply 
SF-6D to measure quality of life among a large, represent-
ative community-based sample of patients with hyper-
tension in rural area in China. SF-6D was capable to 
measure quality of life of Chinese rural population. And 
multiple factors were associated with participant’s quality 
of life. Being female, having two or more comorbidities 
and the health expenditure higher than 2000 RMB were 
associated with worse quality of life; while being farmer, 
having high household income and having stage I and 
above hypertension were associated with better quality of 
life.
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> 80 − 0.025 0.025
Education (ref: Illiteracy)
Primary − 0.001 0.010
Junior 0.006* 0.013
Senior or above − 0.017 0.021
Marital status (ref: Married)
Others − 0.019 0.019
Occupation (ref: Others)
Famers 0.032** 0.011
Way of residence (ref: Living alone)
Living with a spouse 0.016 0.013
Others 0.017 0.016
Health insurance (ref: Yes)
No − 0.030 0.024
Comorbid diseases (ref:1)
2 − 0.066** 0.009
> 3 − 0.098** 0.015
Hypertension stages (ref: Normotensive)
Stage I 0.047** 0.010
Stage II 0.079** 0.013
Stage III 0.095** 0.016
Health expenditure (RMB) (ref: < 2000)
2000–3999 − 0.042** 0.011
4000–5999 − 0.046** 0.013
> 6000 − 0.071** 0.010
Household income (RMB) (ref: < 5000)
5000–9999 0.015 0.012
10,000–14,999 0.045* 0.013
> 15,000 0.064* 0.011
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